| MIC | PAC | FC | PDCa | UCa | AG | FA |
---|---|---|---|---|---|---|---|
Gal-3 | |||||||
 (++) | 100% | 73% | 0% | 0% | 0% | 0% | 0% |
  (+) | 0% | 27% | 0% | 0% | 100% | 0% | 0% |
  (F+) | 0% | 0% | 11% | 50% | 0% | 0% | 28% |
  (−) | 0% | 0% | 73% | 50% | 0% | 100% | 72% |
CK19 | |||||||
  (++) | 75% | 88% | 0% | 0% | 0% | 0% | 0% |
  (+) | 25% | 61% | 0% | 0% | 100% | 0% | 0% |
  (F+) | 0% | 0% | 33% | 50% | 0% | 20% | 28% |
  (−) | 0% | 0% | 67% | 50% | 0% | 80% | 72% |
HBME-1 | |||||||
  (++) | 75% | 85% | 0% | 0% | 0% | 0% | 0% |
  (+) | 17% | 10% | 0% | 0% | 0% | 0% | 0% |
  (F+) | 8% | 0% | 11% | 50% | 0% | 10% | 11% |
  (−) | 0% | 5% | 89% | 50% | 100% | 90% | 56% |
Cyclin D1 | |||||||
  (++) | 100% | 95% | 0% | 0% | 0% | 0% | 0% |
  (+) | 0% | 0% | 0% | 50% | 0% | 0% | 0% |
  (F+) | 0% | 0% | 11% | 50% | 100% | 0% | 17% |
  (−) | 0% | 5% | 89% | 0% | 0% | 100% | 83% |
Ki-67 L.I. (mean percentage | |||||||
 | 5.2% | 7.1% | 3.3% | 10% | 65% | < 1% | 2.9% |